Search Results - "Nachtigall, Lila"

Refine Results
  1. 1

    The Women's Health Initiative trial and related studies: 10 years later: A clinician's view by Gurney, Elizabeth P., Nachtigall, Margaret J., Nachtigall, Lila E., Naftolin, Frederick

    “…•10 years after the WHI, new data is changing clinical menopause management.•Hormone therapy is safe in carefully screened perimenopausal women.•Estrogen and…”
    Get full text
    Journal Article
  2. 2

    Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment [version 1; peer review: 3 approved] by Naftolin, Frederick, Friedenthal, Jenna, Nachtigall, Richard, Nachtigall, Lila

    Published in F1000 research (2019)
    “…Reports have correlated the use of estrogen for the treatment of menopausal symptoms with beneficial effects on the cardiovascular system. Molecular,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Therapy Nonhormonal treatment of hot flashes-a viable alternative? by Nachtigall, Lila E

    Published in Nature reviews. Endocrinology (01-02-2010)
    “…A new study published in the Journal of Clinical Oncology has ascertained the efficacy of selective serotonin-reuptake inhibitors, serotonin and norepinephrine…”
    Get full text
    Journal Article
  6. 6

    Nonhormonal treatment of hot flashes—a viable alternative? by Nachtigall, Lila E.

    Published in Nature reviews. Endocrinology (01-02-2010)
    “…A new study published in the Journal of Clinical Oncology has ascertained the efficacy of selective serotonin-reuptake inhibitors, serotonin and norepinephrine…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women by Nachtigall, Margaret J., Jessel, Rebecca H., Flaumenhaft, Robert, Nachtigall, Richard, Yoles, Israel, Naftolin, Frederick, Nachtigall, Lila E.

    Published in Menopause (New York, N.Y.) (01-03-2011)
    “…OBJECTIVE:The purpose of this study was to assess the effect of DT56a (Femarelle), a selective estrogen receptor modulator, on platelet function in normal and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach by Nachtigall, Lila E, Baber, Rodney J, Barentsen, Ronald, Durand, Nancy, Panay, Nick, Pitkin, Joan, van de Weijer, Peter H M, Wysocki, Susan

    “…Vasomotor symptoms are the most common menopausal symptom experienced by women and the leading reason menopausal women seek health care advice. The recent…”
    Get more information
    Journal Article
  17. 17
  18. 18

    The 2017 hormone therapy position statement of The North American Menopause Society

    Published in Menopause (New York, N.Y.) (01-07-2017)
    “…ABSTRACTThe 2017 Hormone Therapy Position Statement of The North American Menopause Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society by Portman, David J, Gass, Margery L.S

    Published in Menopause (New York, N.Y.) (01-10-2014)
    “…BACKGROUNDIn 2012, the Board of Directors of the International Society for the Study of Women’s Sexual Health (ISSWSH) and the Board of Trustees of The North…”
    Get full text
    Journal Article Conference Proceeding